Search

You searched for "ESCRS"

374 results found

A rare case of bilateral multifocal vitelliform dystrophy

1 October 2026 | | EYE - Vitreo-Retinal
Vitelliform macular dystrophies are a subset of retinal dystrophies that result in the accumulation of lipofuscin, commonly in the macula leading to the formation of characteristic vitelliform lesions [1]. Most cases have a solitary lesion in the macula, but rarely...

A Doctors.net.uk app and more security woes

1 December 2017 | | EYE - General
Doctors.net.uk gets a new app The Doctors.net.uk website is well known in the medical community. Its online services started 20 years ago, in 1998! Since then it has retained its core features of providing email accounts and also an online...

OrCam MyEye – innovative sight assistance (Part 1)

3 June 2021 | | EYE - General
For Jun/Jul 20201 and Aug/Sep 2021 we have a two-part review (see Part 2 here) of an innovative piece of sight impairment technology. The device is called a MyEye, made by OrCam. I was given the opportunity to use the...

Stephen Connell joins Birmingham Optical Ophthalmology division as Clinical Sales Specialist

27 June 2023 | Research & Development
Stephen began his career in Ophthalmology in 2006 as an Ophthalmic Science Practitioner joining the Royal Hallamshire Hospital.

Oertli launches OS 4 Up™ in CE-certified markets

24 March 2026 | Company Profiles, Research & Development
Oertli Instrumente AG announces the commercial launch of its new surgical platform, OS 4 Up™, for cataract and vitreoretinal surgery. Development, design and production are carried out entirely at the company's headquarters in Berneck, Switzerland. The family-run company is thus...

In conversation with Charles Leclercq (ARxVision)

5 October 2022 | | EYE - General
Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...

Quiz Apr/May 2023

3 April 2023 | | EYE - General
History A 76-year-old female presented at her local district general hospital with right decreased visual acuity, glare, and foreign body sensation, in addition to longer-term dry eyes. She was otherwise well. Her past medical history included hypertension. On examination: vision...

White dot syndromes

1 September 2015 | | EYE - Vitreo-Retinal
It is fair to say that trainees and consultants who are not medical retina specialists are a bit scared of the so called retinal ‘white dot syndromes’. It is easy to understand why this is the case, as almost every...

More sensitive visual acuity test for age-related macular degeneration

1 October 2016 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...

Simplified Ophthalmic Statistics (SOS) Part 1: An introduction to data – how do we classify it and why does it matter?

1 April 2018 | | EYE - General
Introductory statistics courses often start by explaining how data can be classified in different ways. What is not always clear is why you would need to know this. Catey Bunce and Tafadzwa Young-Zvandasara explain. The term data can be applied...

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

1 February 2017 | | EYE - Vitreo-Retinal
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...